|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | G01N 33/68 | (2006.01) |
| (11) | Number of the document | 2900831 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13840682.2 |
| Date of filing the European patent application | 2013-09-26 | |
| (97) | Date of publication of the European application | 2015-08-05 |
| (45) | Date of publication and mention of the grant of the patent | 2018-11-21 |
| (46) | Date of publication of the claims translation | 2019-01-25 |
| (86) | Number | PCT/US2013/061914 |
| Date | 2013-09-26 |
| (87) | Number | WO 2014/052585 |
| Date | 2014-04-03 |
| (30) | Number | Date | Country code |
| 201213629321 | 2012-09-27 | US |
| (72) |
CRAWFORD, Brett, E., US
BROWN, Jillian, R., US
GLASS, Charles, A., US
BEITEL, Jim, R., US
JACKMAN, Robin, M., US
|
| (73) |
BioMarin Pharmaceutical Inc.,
105 Digital Drive, Novato, CA 94949,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Glikano neredukuojančio galo galinių junginių kiekybinis įvertinimas |
| QUANTIFICATION OF NON-REDUCING END GLYCAN RESIDUAL COMPOUNDS |
| Payment date | Validity (years) | Amount | |
| 2024-08-20 | 12 | 289.00 EUR |
| 2025-09-26 |